Mega Labs S.A. acquired three skin treatment brands from GlaxoSmithKline plc (LSE:GSK) on March 5, 2020. The three brands includes Physiogel, Sunmax and Clindo. The brands generate annual sales close to $19 million in Brazil, Mexico, Chile, and Colombia. Greenhill & Co., Inc. (NYSE:GHL) acted as financial advisor to GlaxoSmithKline plc (LSE:GSK) in this transaction. Mega Labs S.A. completed the acquisition of three skin treatment brands from GlaxoSmithKline plc (LSE:GSK) on March 5, 2020.